BioSpace News Archive

Kinarus Therapeutics Holding AG, a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, published the Annual Report with full year audited consolidated financial results for the year ended 31 December 2022.

ValnevaSE, a specialty vaccine company, announced that its senior management will attend the Jefferies Healthcare Conference, Goldman Sachs Annual Global Healthcare Conference and the Stifel European Healthcare Conference.

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that all participating study sites in the Phase IIb study of pirepemat are activated and recruiting patients.

Anocca AB announces that the company has successfully raised SEK 400 million through an equity financing round led by AMF and Mellby Gård.

THINK Surgical, Inc. recently announced that its TMINI™ Miniature Robotic System has received 510 clearance from the U.S. Food and Drug Administration.

Asieris Pharmaceuticals announced the phase I clinical data of ANTICIPATE Study was published for the first time at the 2023 American Society of Clinical Oncology annual meeting in Chicago.

Athira Pharma, Inc. announced that Company management will participate in the following upcoming investor conferences.

Selecta Biosciences, Inc. (NASDAQ: SELB) today announced the presentation of positive data from the Phase 3 DISSOLVE I and DISSOLVE II double-blind, placebo-controlled studies of SEL-212 in patients with chronic refractory gout.

BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) today announced that the company will present two abstracts featuring data on oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of hereditary angioedema (HAE) at the 2023 European Academy of Allergy and Clinical Immunology (EAACI) congress which is being held in Hamburg, Germany from June 9 – 11, 2023.

Bicycle Therapeutics plc today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference in New York, NY on June 7th, 2023 at 10:30 a.m. ET.